-
3740 E Southern Ave, Ste 210
Mesa, AZ 85206 -
Monday–Friday, 9:00 AM – 6:00 PM MST
by appointment only -
Saturday
By Appointment -
Sunday
Closed
Could Spravato for treatment-resistant depression help when several antidepressants have not worked? Many adults in Mesa reach this point and start to wonder. Spravato is a nasal spray made from esketamine. Whether it fits depends on your history, your health, and what you have already tried.
This guide explains how clinicians define treatment-resistant depression and how the spray works. It also covers who is usually considered and what safety steps come with it. You can also read about treatment-resistant depression care in Mesa to see how local care is organized. Knowing the basics helps you ask better questions at your next visit. Clear answers can make the decision feel less overwhelming.
Depression is more than a low mood that fades with time. For some people, symptoms last even after careful treatment. According to the National Institute of Mental Health, researchers are working to develop and test therapies for people with treatment-resistant depression. This group does not improve after trying several treatment options.
Many clinicians use the term when symptoms last after at least two adequate antidepressant trials. An adequate trial means the right dose, taken as prescribed, for long enough to judge the result.
A medication may seem to have failed when something else is in the way. Missed doses, short trials, sleep apnea (breathing pauses during sleep), thyroid problems, and alcohol use can all blunt a response. So can a bipolar pattern that no one has spotted yet. You can read more about reasons depression can persist despite medication before deciding that a treatment has truly run its course.
Spravato is the brand name for esketamine. Most common antidepressants act on serotonin and norepinephrine. These include SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Esketamine works on a different system. It affects glutamate, the brain’s main excitatory chemical messenger, by blocking a receptor called NMDA (N-methyl-D-aspartate).
Researchers believe this action may help brain cells form new connections. Experts are still studying exactly how it works. Because it targets a different pathway, it may help some people who did not respond to serotonin-based medicines. Depression is also a broad diagnosis, and our depression treatment page explains how its different forms are evaluated.
Providers weigh several factors before recommending Spravato for treatment-resistant depression. No single checklist fits everyone. Providers often look at the following.
Your provider will ask which medications you tried, at what doses, and for how long. Past therapy and lifestyle changes help show the full picture. So do brain stimulation treatments such as transcranial magnetic stimulation. This uses magnetic pulses to activate brain areas linked to mood. A clear timeline makes it easier to decide whether a new approach makes sense.
For people in Mesa, logistics count too. Think about how far you would travel and how often you can step away from work or family duties. Also think about who could drive you. Spravato for treatment-resistant depression asks for a steady routine over several weeks. A plan you can realistically keep often matters as much as the medication itself.
Esketamine can cause a short rise in blood pressure, so heart and blood vessel health is reviewed carefully. An aneurysm can make the treatment unsafe. This is a bulging, weakened area in a blood vessel wall. A history of bleeding in the brain can also rule it out.
According to the National Alliance on Mental Illness, alcohol and other sedating substances can increase sleepiness and sedation. These include benzodiazepines (a class of anti-anxiety sedatives) and opioids (strong pain medicines). The same source notes that patients should be evaluated for misuse and dependence before and during treatment.
Before treatment begins, most practices complete a full psychiatric evaluation. This visit covers your symptoms, sleep, energy, past diagnoses, and how depression affects work and relationships. A clinic that offers Spravato treatment will also review your medical history and current medications.
Screening for bipolar disorder matters here. Some medicines can worsen mood swings in people with an undiagnosed bipolar pattern. Your provider may also check your blood pressure and ask about your heart health. The goal is to decide whether Spravato for treatment-resistant depression fits your situation, not simply to start a new medicine.
A good evaluation ends with a talk about your options, including the benefits, the limits, and the alternatives. You should leave knowing why a treatment is or is not recommended.
Spravato is not a take-home medicine. It is available only through a safety program called REMS (Risk Evaluation and Mitigation Strategy). Only certified clinics can give it, and only to patients enrolled in the program.
During a session, you spray the medicine into your nose yourself while a provider supervises. Clinics commonly follow these steps.
Some people feel sleepy, dizzy, or disconnected from their surroundings after a dose. Staff watch these effects until they pass. That way, you do not leave while still affected.
Treatment follows a set timetable, so planning ahead helps. According to MedlinePlus, the usual schedule is twice weekly during weeks 1 to 4. It then drops to weekly during weeks 5 to 8, and to weekly or every two weeks from week 9 onward. Patients are monitored for at least 2 hours after each dose.
Spravato works best as one part of a plan. Therapy, sleep habits, movement, and regular follow-up visits still matter. Stopping early or missing sessions can raise the chance of symptoms returning, so talk with your provider before changing anything. If you must miss a session, contact the office early so the plan can be adjusted safely.
There is no single number for every patient. Many clinicians look for at least two adequate trials. Your provider will also consider your full history and how severe your symptoms are.
It is generally used together with an oral antidepressant. Your provider will review everything you take, since some medicines and substances raise the risk of sedation.
Responses vary. Some people notice changes within the first weeks, while others need more time. Your provider will check your progress at regular points.
Not exactly. Esketamine is one of the two mirror-image forms of ketamine. Spravato is approved by the U.S. Food and Drug Administration (FDA) and comes with its own safety program. Other forms of ketamine are used differently and are not interchangeable with it.
No. You will need someone to take you home. Wait until the next day, after a restful night of sleep, before driving.
Coverage differs by plan. Some plans require prior authorization, which means the insurer must approve treatment first. Contact your insurer and your provider’s office to learn what applies to you.
Choosing a new depression treatment can feel heavy, especially after earlier medicines fell short. A clear plan starts with an honest look at what you have tried and how you feel now. Then you and your provider can weigh the benefits, the time it takes, and the safety steps.
Write down your questions before your visit. Ask about eligibility, scheduling, monitoring, and what happens if the treatment does not help. Understanding Spravato for treatment-resistant depression is a first step, and the final choice should fit your health and your goals.
Disclaimer: This article is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. Always speak with a qualified healthcare provider about your individual situation. If you are in crisis or having thoughts of harming yourself, contact your local emergency services or a crisis line right away.